-
June 6,2022
Press release
Notice Concerning the Completion of Subject Enrollment for the Phase I/IIa Clinical Study of Antibody-Inducing Peptide FPP003 [PDF file]
-
April 1,2022
Press release
Announcement of the start of joint research with Kumamoto University [PDF file]
-
January 20,2022
Press release
Notice of Agreement between FunPep and EPS Innovative Medicine on Collaboration in China Business [PDF file]
-
August 19,2021
Press release
Announcing the Start of Administration of Functional Peptide SR-0379 to Subjects in Phase III Clinical Trial [PDF file]
-
August 13,2021
Press release
FunPep Signs Joint Research Agreement for a Next-generation Drug Formulation Technology for Antibody Inducing Peptides Using Microneedle Array Patch [PDF file]
-
June 16,2021
Press release
Announcing the Start of Phase III Clinical Trials for Functional Peptide SR-0379 [PDF file]
-
June 1,2021
Press release
Submission of Clinical Trial Plan for a Phase III Clinical Trial of Functional Peptide SR-0379 [PDF file]
-
January 29,2021
Press release
Announcement of Newly Developed Antibody-inducing Peptide Compound [PDF file]
-
August 21,2020
Press release
Announcement of Fund Raising through Third Party Allocation of New Shares [PDF file]
-
April 8,2020
Press release
AnGes and Osaka University to Jointly Develop DNA Vaccine for COVID-19 [PDF file]